Literature DB >> 2330915

Use of angiotensin converting enzyme inhibitors for the treatment of focal segmental glomerulosclerosis.

D S Fitzwater, B H Brouhard, R J Cunningham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2330915     DOI： 10.1001/archpedi.1990.02150290016012

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN： 0002-922X


× No keyword cloud information.
  5 in total

Review 1.  Is there any reason to lower proteinuria in a child with nephrotic-range proteinuria who is not clinically edematous?

Authors:  D Kees-Folts
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

2.  Renin-angiotensin-aldosterone system inhibitors in pediatric focal segmental glomerulosclerosis.

Authors:  Shreya Kangovi; Meredith Edwards; Stephen Woloszynek; Nandita Mitra; Harold Feldman; Bernard S Kaplan; Kevin E Meyers
Journal:  Pediatr Nephrol       Date:  2011-11-25       Impact factor: 3.714

3.  Effects of enalapril on adriamycin-induced nephrosis.

Authors:  K C Irwin; B H Brouhard; S Satoh; N T Stowe
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

4.  Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome.

Authors:  D S Milliner; B Z Morgenstern
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

5.  Enalapril dosage in steroid-resistant nephrotic syndrome.

Authors:  Arvind Bagga; Basanagoud D Mudigoudar; Pankaj Hari; Vandita Vasudev
Journal:  Pediatr Nephrol       Date:  2003-11-25       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.